Langerhans cells arise from monocytes in vivo

Nature Immunology

Volumn 7, Issue 3, 2006, Pages 265-273

  Ginhoux, Florent ^a   Tacke, Frank ^a   Angeli, Veronique ^a   Bogunovic, Milena ^a   Loubeau, Martine ^a   Dai, Xu Ming ^b   Stanley, E Richard ^b   Randolph, Gwendalyn J ^a   Merad, Miriam ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CHEMOKINE RECEPTOR; GR 1 PROTEIN, MOUSE; GR-1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL LABELING; CELL MATURATION; CELL TRANSFER; CELL TYPE; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LANGERHANS CELL; LEUKOCYTE MIGRATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STEADY STATE; ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; CONGENIC STRAIN; CYTOLOGY; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, CONGENIC; MONOCYTES; RECEPTORS, CHEMOKINE;

EID: 33645953640     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1307     Document Type: Article

References (53)

1. Hemmi, H. et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells. Int. Immunol. 13, 695-704 (2001).
2. Kripke, M.L., Munn, C.G., Jeevan, A., Tang, J.M. & Bucana, C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145, 2833-2838 (1990).
3. Schuler, G. & Steinman, R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161, 526-546 (1985).
4. Tang, H.L. & Cyster, J.G. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 284, 819-822 (1999).
5. Mayerova, D., Parke, E.A., Bursch, L.S., Odumade, O.A. & Hogquist, K.A. Langerhans cells activate naive self-antigen-specific CD8 Tcells in the steady state. Immunity 21, 391-400 (2004).
6. + dendritic cells but not by Langerhans cells. Science 301, 1925-1928 (2003).
7. Kissenpfennig, A. et al. Dynamics and function of Langerhans cells in viva: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22, 643-654 (2005).
8. Bennett, C.L. et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169, 569-576 (2005).
9. Merad, M. et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3, 1135-1141 (2002).
10. Witmer-Pack, M.D. et al. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J. Cell Sci. 104, 1021-1029 (1993).
11. Takahashi, K., Naito, M. & Shultz, L.D. Differentiation of epidermal Langerhans cells in macrophage colony-stimulating-factor-deficient mice homozygous for the osteopetrosis (op) mutation. J. Invest. Dermatol. 99, 46S-47S (1992).
12. Wiktor-Jedrzejczak, W.W., Ahmed, A., Szczylik, C. & Skelly, R.R. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J. Exp. Med. 156, 1516-1527 (1982).
13. Wiktor-Jedrzejczak, W. & Gordon, S. Cytokine regulation of the macrophage (MΦ) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol. Rev. 76, 927-947 (1996).
14. del Hoyo, G.M. et al. Characterization of a common precursor population for dendritic cells. Nature 415, 1043-1047 (2002).
15. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF-α. J. Exp. Med. 184, 695-706 (1996).
16. + subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 163, 1409-1419 (1999).
17. Geissmann, F. et al. Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187, 961-966 (1998).
18. + cells differentiate into Langerhans cells. Nat. Immunol. 2, 1151-1158 (2001).
19. Borkowski, T.A., Letterio, J.J., Farr, A.G. & Udey, M.C. A role for endogenous transforming growth factor β1 in Langerhans cell biology: the skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184, 2417-2422 (1996).
20. Dai, X.M. et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99, 111-120 (2002).
21. Cecchini, M.G. et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120, 1357-1372 (1994).
22. Pixley, F.J. & Stanley, E.R. CSF-1 regulation of the wandering macrophage: Complexity in action. Trends Cell Biol. 14, 628-638 (2004).
23. Byrne, P.V., Guilbert, L.J. & Stanley, E.R. Distribution of cells bearing receptors for a colony-stimulating factor (CSF-1) in murine tissues. J. Cell Biol. 91, 848-853 (1981).
24. Qu, C. et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 200, 1231-1241 (2004).
25. Sunderkotter, C. et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172, 4410-4417 (2004).
26. Dai, X.M., Zong, X.H., Akhter, M.P. & Stanley, E.R. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J. Bone Miner. Res. 19, 1441-1451 (2004).
27. Geissmann, F., Jung, S. & Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
28. Passlick, B., Flieger, D. & Ziegler-Heitbrock, H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534 (1989).
29. +) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 196, 517-527 (2002).
30. Tacke, F. et al. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. (in the press).
31. Merad, M. et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10, 510-517 (2004).
32. - dendritic cells. Eur. J. Immunol. 31, 3403-3412 (2001).
33. Schaerli, P., Willimann, K., Ebert, L.M., Walz, A. & Moser, B. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23, 331-342 (2005).
34. op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 98, 74-84 (2001).
35. Roth, P. & Stanley, E.R. The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol. 181, 141-167 (1992).
36. Hume, D.A. & Favot, P. Is the osteopetrotic (op(op mutant) mouse completely deficient in expression of macrophage colony-stimulating factor? J. Interferon Cytokine Res. 15, 279-284 (1995).
37. + myeloid progenitors are the main source of Langerhans cells. Blood (2005).
38. Hannum, C. et al: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368, 643-648 (1994).
39. Hume, D.A., Pavli, P., Donahue, R.E. & Fidler, I.J. The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J. Immunol. 141, 3405-3409 (1988).
40. Tushinski, R.J. et al. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28, 71-81 (1982).
41. Metcalf, D. The granulocyte-macrophage colony-stimulating factors. Science 229, 16-22 (1985).
42. Korn, A.P., Henkelman, R.M., Ottensmeyer, F.P. & Till, J.E. Investigations of a stochastic model of haemopoiesis. Exp. Hematol. 1, 362-375 (1973).
43. Nakahata, T., Gross, A.J. & Ogawa, M. A stochastic model of self-renewal and commitment to differentiation of the primitive hemopoietic stem cells in culture. J. Cell. Physiol. 113, 455-458 (1982).
44. Lagasse, E. & Weissman, I.L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89, 1021-1031 (1997).
45. Romani, N., Schuler, G. & Fritsch, P. Ontogeny of la-positive and Thy-l-positive leukocytes of murine epidermis. J. Invest. Dermatol. 86, 129-133 (1986).
46. + dendritic epidermal cells in the perinatal period. J. Immunol. 143, 2431-2438 (1989).
47. Tripp, C.H. et al. Ontogeny of Langerin/CD207 expression in the epidermis of mice. J. Invest. Dermatol. 122, 670-672 (2004).
48. Beverley, P.C., Egeler, R.M., Arceci, R.J. & Pritchard, J. The Nikolas Symposia and histiocytosis. Nat. Rev. Cancer 5, 488-494 (2005).
49. Rolland, A. et al. Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J. Immunol. 174, 3067-3071 (2005).
50. + progenitor-derived dendritic cell vaccine. Cancer Res. 61, 6451-6458 (2001).
51. Boring, L. et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100, 2552-2561 (1997).
52. Cook, D.N. et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12, 495-503 (2000).
53. Van Rooijen, N. & Sanders, A. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174, 83-93 (1994).